BIO-GATE AG O.N. KONV.

BIO-GATE AG O.N. KONV.'s next confirmed earnings release is scheduled for March 3, 2027.

As of December 31, 2025, BIO-GATE AG O.N. KONV. has 2.04M shares outstanding.

As of December 31, 2025, BIO-GATE AG O.N. KONV. maintains a current ratio of 2.46, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, BIO-GATE AG O.N. KONV.'s stock has declined approximately 63.77% over the past 52 weeks. The 50-day moving average sits at 2.76, while the 200-day moving average is 8.59.

As of December 31, 2025, BIO-GATE AG O.N. KONV. holds 704,933.50 in cash and equivalents against 52,535.98 in total debt, resulting in a net debt position of -652,397.52. Total book value stands at 1.53M, with working capital of 1.66M providing operational flexibility.

BIO-GATE AG O.N. KONV.'s most recent stock split took place on July 28, 2026 with a 5:1 split ratio.